(Q43413117)

23 November 2017

Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock (English)

1 reference

23 November 2017

0 references

1 reference

Alexander Geppert

1

1 reference

23 November 2017

Angela Steiner

2

1 reference

23 November 2017

Georg Delle-Karth

3

1 reference

23 November 2017

Gottfried Heinz

4

1 reference

23 November 2017

Kurt Huber

5

1 reference

23 November 2017

20 June 2003

1 reference

23 November 2017

Intensive Care Medicine

1 reference

23 November 2017

29

1 reference

23 November 2017

8

1 reference

23 November 2017

1384-1389

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-003-1827-7

23 November 2017

0 references

cites work

Procalcitonin: a new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation

1 reference

12 December 2020

Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS

1 reference

12 December 2020

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

1 reference

12 December 2020

Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies

1 reference

12 December 2020

Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?

1 reference

12 December 2020

Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients

1 reference

12 December 2020

Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit

1 reference

12 December 2020

Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6

1 reference

12 December 2020

Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients.

1 reference

12 December 2020

Differentiated therapy with prostaglandin E1 (alprostadil) after orthotopic liver transplantation: the usefulness of procalcitonin (PCT) and hepatic artery resistive index (RI) for the evaluation of early graft function and clinical course.

1 reference

12 December 2020

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

12 December 2020

The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function

1 reference

12 December 2020

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine

1 reference

12 December 2020

Procalcitonin used as a marker of infection in the intensive care unit

1 reference

12 December 2020

Procalcitonin, a donor-specific predictor of early graft failure-related mortality after heart transplantation.

1 reference

12 December 2020

Biomarkers of sepsis: is procalcitonin ready for prime time?

1 reference

12 December 2020

1 reference

12 December 2020

Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation

1 reference

12 December 2020

The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study

1 reference

12 December 2020

Dear Sirs, What is your PCT?

1 reference

12 December 2020

Emergency aortic valve replacement for critical aortic stenosis. A lifesaving treatment for patients with cardiogenic shock and multiple organ failure.

1 reference

12 December 2020

10.1007/S00134-003-1827-7

Identifiers

DOI

1 reference

23 November 2017

1 reference